We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
RE: COVID-19 severity by vaccination status in the NCI COVID-19 and Cancer Patients Study (NCCAPS).
- Authors
Song, Shan
- Abstract
Meanwhile the CAR T-cell therapy, which is an important cancer treatment-related toxicity, can induce cytokine release syndrome (CRS) ([3],[4]), which is an acute systemic inflammatory syndrome resulting from rapid immune activation and characterized by fever and multiple organ dysfunction that can progress to life threatening ([4]). In their study, they found a statistically significant association with a lower incidence of severe COVID-19 disease in fully vaccinated patients with cancer after infection with COVID-19 compared with those unvaccinated or partially vaccinated cancer patients. I thank Dr Korde and colleagues ([1]) for their valuable study to investigate whether the SARS-CoV-2 vaccination was associated with a lower incidence of COVID-19 severity in a longitudinal study in which adult cancer patients infected with COVID-19 were enrolled.
- Subjects
VACCINATION status; COVID-19; COVID-19 vaccines; CANCER patients
- Publication
JNCI: Journal of the National Cancer Institute, 2023, Vol 115, Issue 6, p766
- ISSN
0027-8874
- Publication type
Article
- DOI
10.1093/jnci/djad045